Determination of serum neutralizing antibodies reveals important difference in quality of antibodies against pertussis toxin in children after infection.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
26 03 2021
Historique:
received: 24 12 2020
revised: 17 02 2021
accepted: 19 02 2021
pubmed: 9 3 2021
medline: 25 5 2021
entrez: 8 3 2021
Statut: ppublish

Résumé

To determine neutralizing antibodies to pertussis toxin (PTNAs) in children with suspected pertussis and to compare results of PTNAs and anti-PT IgG antibodies. 172 hospitalized children with suspected pertussis were included. Pertussis was confirmed by culture, PCR and/or serology. PTNAs were determined by Chinese hamster ovary (CHO) cell assay. A correlation between titers of PTNAs and anti-PT IgG levels was noticed in 172 patients (Spearman R = 0.68, P < 0.001). Subjects with same concentrations of anti-PT IgG antibodies could have different titers of PTNAs and the maximum difference observed reached to 1024 times in ELISA-confirmed patients. Moreover, subjects with same titers of PTNAs could have different concentrations of anti-PT IgG antibodies. Our results indicated that in some children high concentrations of anti-PT IgG antibodies do not always mean effective PTNAs induced after infection, stressing the importance of detecting PTNAs after infection and vaccination. Clinical trial registry: Not applicable.

Identifiants

pubmed: 33678454
pii: S0264-410X(21)00225-5
doi: 10.1016/j.vaccine.2021.02.045
pii:
doi:

Substances chimiques

Antibodies, Bacterial 0
Antibodies, Neutralizing 0
Immunoglobulin G 0
Pertussis Toxin EC 2.4.2.31

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1826-1830

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yuxiao Zhang (Y)

Department of Medical Microbiology, Capital Medical University, Beijing, China.

Yarong Li (Y)

Department of Infectious Diseases, Xi'an Children's Hospital, Xi'an, China. Electronic address: lyr640101@163.com.

Zhiyun Chen (Z)

Department of Medical Microbiology, Capital Medical University, Beijing, China.

Xiaoguai Liu (X)

Department of Infectious Diseases, Xi'an Children's Hospital, Xi'an, China.

Xiaokang Peng (X)

Department of Infectious Diseases, Xi'an Children's Hospital, Xi'an, China.

Qiushui He (Q)

Department of Medical Microbiology, Capital Medical University, Beijing, China; Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland. Electronic address: Qiushui.He@utu.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH